Compound 21, a selective agonist of angiotensin AT(2) receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo

BACKGROUND AND PURPOSE: Angiotensin AT (2) receptors are upregulated in disease states such as atherosclerosis and blockade of the AT(2) receptors exacerbates plaque formation. Direct stimulation of these receptors is anti‐atherogenic but the mechanisms and pathways involved remain unknown. We exami...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Pharmacol
Autors principals: Sampson, Amanda K, Irvine, Jennifer C, Shihata, Waled A, Dragoljevic, Dragana, Lumsden, Natalie, Huet, Olivier, Barnes, Tyrone, Unger, Thomas, Steckelings, Ulrike M, Jennings, Garry L, Widdop, Robert E, Chin‐Dusting, Jaye P F
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2015
Matèries:
Themed Section: Research Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4742292/
https://ncbi.nlm.nih.gov/pubmed/25560767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13063
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars